Flatiron Health Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Flatiron Health Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11151
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Flatiron Health Inc (Flatiron Health) a subsidiary of F. Hoffmann-La Roche Ltd, is a healthcare technology company which develops a learning healthcare system in oncology. The company offers a web-based business and clinical intelligence data platform that integrates and structures disparate information systems to produce a view of the patient population; oncoEMR which helps organizations to optimize clinical decision making process and supports data collection and reporting; oncobilling, a practice management system integrates into oncoEMR to provide insights into financial viability of practice; oncoanalytics platform helps organizations to extract meaningful insights from data; oncotrails solution allows firms to manage their clinical trial programs. Flatiron Health caters services to oncologists, academics, hospitals, life science researchers, and regulatory bodies. Flatiron Health is headquartered in New York, the US.

Flatiron Health Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Flatiron Health Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Flatiron Health Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Flatiron Health Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Flatiron Health Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Flatiron Health Inc, Medical Devices Deals, 2012 to YTD 2018 9
Flatiron Health Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Flatiron Health Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Flatiron Health Raises USD175 Million in Series C Financing 11
Flatiron Health Raises US$130 Million In Series B Financing 13
Partnerships 15
Bristol-Myers Squibb Expands Collaboration with Flatiron Health 15
Flatiron Health Enters into Research Agreement with US Food and Drug Administration 16
Flatiron Health Partners with Celgene 17
Flatiron Health Partners with Amgen 18
Guardant Health Enters into Agreement with Flatiron Health 19
Foundation Medicine Enters into Co-Development Agreement with Flatiron Health 20
Acquisition 21
Roche Acquires Flatiron Health for USD1.9 Billion 21
Flatiron Health Inc – Key Competitors 22
Flatiron Health Inc – Key Employees 23
Flatiron Health Inc – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 25
Corporate Communications 25
Apr 03, 2017: Flatiron Health Announces Former Groupon and Google Executive Jason Harinstein to Join as Chief Financial Officer 25
Government and Public Interest 26
May 14, 2018: Pivotal Study Validates Real-World Mortality Endpoint for Oncology Research 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
Flatiron Health Inc, Pharmaceuticals & Healthcare, Key Facts 2
Flatiron Health Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Flatiron Health Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Flatiron Health Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Flatiron Health Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Flatiron Health Inc, Medical Devices Deals, 2012 to YTD 2018 9
Flatiron Health Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Flatiron Health Raises USD175 Million in Series C Financing 11
Flatiron Health Raises US$130 Million In Series B Financing 13
Bristol-Myers Squibb Expands Collaboration with Flatiron Health 15
Flatiron Health Enters into Research Agreement with US Food and Drug Administration 16
Flatiron Health Partners with Celgene 17
Flatiron Health Partners with Amgen 18
Guardant Health Enters into Agreement with Flatiron Health 19
Foundation Medicine Enters into Co-Development Agreement with Flatiron Health 20
Roche Acquires Flatiron Health for USD1.9 Billion 21
Flatiron Health Inc, Key Competitors 22
Flatiron Health Inc, Key Employees 23
Flatiron Health Inc, Other Locations 24

List of Figures
Flatiron Health Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Flatiron Health Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Flatiron Health Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Flatiron Health Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Flatiron Health Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Flatiron Health Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Flatiron Health Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Flatiron Health Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Flatiron Health Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Flatiron Health Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Schuler AG:企業の戦略・SWOT・財務情報
    Schuler AG - Strategy, SWOT and Corporate Finance Report Summary Schuler AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Power Finance Corporation Ltd.:企業の戦略・SWOT・財務情報
    Power Finance Corporation Ltd. - Strategy, SWOT and Corporate Finance Report Summary Power Finance Corporation Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Genesis Energy Ltd (GNE):電力:M&Aディール及び事業提携情報
    Summary Genesis Energy Ltd (Genesis) is an energy company. It generates electricity and supplies that on retail and wholesale basis. The company also supplies gas and LPG, and related services to end-users; and sells and purchases electricity derivatives. Genesis produces power using coal, gas, hydr …
  • HC Slingsby Plc:企業の戦略・SWOT・財務情報
    HC Slingsby Plc - Strategy, SWOT and Corporate Finance Report Summary HC Slingsby Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • SaskEnergy Incorporated:企業の戦略的SWOT分析
    SaskEnergy Incorporated - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • The Trendlines Group Ltd (42T):製薬・医療:M&Aディール及び事業提携情報
    Summary The Trendlines Group Ltd (Trendlines) is a commercialization company that invents, discovers, invests, and incubates medical and agricultural technologies. The company offers business incubation, partner and channel development, market strategies, business plans, research and development and …
  • Medusa Mining Ltd:企業の戦略・SWOT・財務情報
    Medusa Mining Ltd - Strategy, SWOT and Corporate Finance Report Summary Medusa Mining Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • AxoGen Inc (AXGN):医療機器:M&Aディール及び事業提携情報
    Summary AxoGen Inc (AxoGen), formerly LecTec Corp is a provider of surgical solutions to measure and monitor nerve functions. The company offers products such as AxoTouch two-point discriminator, AxoGuard nerve connector, Avance nerve graft, AcroVal NSTMS and AxoGuard nerve protector products, among …
  • Sumitomo Precision Products Co Ltd:企業の戦略・SWOT・財務情報
    Sumitomo Precision Products Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Sumitomo Precision Products Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Highmark Inc.:企業の戦略・SWOT・財務分析
    Highmark Inc. - Strategy, SWOT and Corporate Finance Report Summary Highmark Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Vectrus Inc (VEC):企業の財務・戦略的SWOT分析
    Vectrus Inc (VEC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Xbrane Biopharma AB (XBRANE):企業の財務・戦略的SWOT分析
    Summary Xbrane Biopharma AB (Xbrane), formerly Xbrane Bioscience AB is a biopharmaceutical company that develops and manufactures complex generic products . The company's product portfolio includes biosimilars and long acting injectables developed for people suffering from critical diseases. It comb …
  • Ameresco Inc (AMRC)-エネルギー分野:企業M&A・提携分析
    Summary Ameresco, Inc. (Ameresco) provides comprehensive energy services, including energy efficiency, infrastructure upgrades, asset sustainability and renewable energy solutions. It also offers energy infrastructure facility upgrade; and development, construction and operation of renewable energy …
  • BKW AG (BKW):電力:M&Aディール及び事業提携情報
    Summary BKW AG (BKW) is an energy and infrastructure company, which plans, builds and operates infrastructure to produce and supply energy. It generates electricity from varied fuel sources such as hydro, nuclear, fossil, and renewable sources primarily, wind and small hydro, besides solar and bioma …
  • Median Technologies SA (ALMDT):医療機器:M&Aディール及び事業提携情報
    Summary Median Technologies SA (Median) is a medical technology company that develops and markets medical imaging solutions. The company offers clinical trials, imaging services for CT, scientific consulting, image and clinical data management, image data processing and site support, managed service …
  • Leukocare AG-製薬・医療分野:企業M&A・提携分析
    Summary Leukocare AG (Leukocare) is a clinical stage biotechnology company that offers technologies for stabilizing proteins to increase shelf-life and to facilitate terminal sterilization by irradiation or gas. The company offers services such as development of individual SPS formulations meeting i …
  • Orexo AB (ORX):製薬・医療:M&Aディール及び事業提携情報
    Summary Orexo AB (Orexo) is a specialty pharmaceutical company that focuses on the research, formulation, development, registration and commercialization of drugs. The company's commercial product portfolio consists of Abstral, Edluar and Zubsolv. its pipeline candidates comprise OX51 for procedure- …
  • Harbour Centre Development Ltd:企業の戦略・SWOT・財務情報
    Harbour Centre Development Ltd - Strategy, SWOT and Corporate Finance Report Summary Harbour Centre Development Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Harbin Electric International Co Ltd:企業の戦略的SWOT分析
    Harbin Electric International Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • MetLife, Inc.:企業のM&A・事業提携・投資動向
    MetLife, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's MetLife, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆